QUINCY BIOSCIENCE LLC has a total of 82 patent applications. It decreased the IP activity by 66.0%. Its first patent ever was published in 2005. It filed its patents most often in Australia, EPO (European Patent Office) and Brazil. Its main competitors in its focus markets pharmaceuticals, foods and drinks and biotechnology are FOODSCIENCE CORP, PHYT IMMUN GMBH and CASH ALAN B.
# | Country | Total Patents | |
---|---|---|---|
#1 | Australia | 7 | |
#2 | EPO (European Patent Office) | 7 | |
#3 | Brazil | 6 | |
#4 | Canada | 6 | |
#5 | China | 6 | |
#6 | Israel | 6 | |
#7 | Republic of Korea | 6 | |
#8 | United States | 6 | |
#9 | WIPO (World Intellectual Property Organization) | 6 | |
#10 | Hong Kong | 5 | |
#11 | Mexico | 5 | |
#12 | New Zealand | 5 | |
#13 | Singapore | 4 | |
#14 | South Africa | 4 | |
#15 | Hungary | 2 | |
#16 | India | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Foods and drinks | |
#3 | Biotechnology |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Therapeutic chemical compounds | |
#3 | Microorganisms | |
#4 | Enzymes | |
#5 | Foods | |
#6 | Special foods | |
#7 | Peptides |
# | Name | Total Patents |
---|---|---|
#1 | Underwood Mark Y | 60 |
#2 | Moyer James R | 13 |
#3 | Mark Y Underwood | 11 |
#4 | Moyer James R Jr | 7 |
#5 | Moyer Jr James R | 3 |
#6 | James R Moyer | 3 |
#7 | Underwood Mark | 2 |
#8 | James R Moyer Jr | 2 |
#9 | Moskal William | 1 |
#10 | Underwood Mark Y My | 1 |
Publication | Filing date | Title |
---|---|---|
AU2017330451A1 | Apoaequorin and vitamin D-containing compositions and methods of using same | |
CN107109430A | The cabbage type rape seed specific promoters identified by microarray analysis | |
AU2015346430A1 | Apoaequorin-containing compositions and methods of using same to treat neuronal inflammation | |
NZ744952A | Methods for alleviating symptoms of multiple sclerosis based on apoaequorin-containing compositions | |
SG11201502418VA | Methods for alleviating symptoms of multiple sclerosis based on apoaequorin-containing compositions | |
SG11201402364WA | Apoaequorin for reducing neuronal injury due to ischemia | |
US2011130336A1 | Method of treating ischemic injury using apoaequorin | |
CA2717322A1 | Apoaequorin-containing compositions and methods of using same | |
US2008287350A1 | Aequorin-containing compositions and methods of using same |